FDA Approves Novartis’ Utibron Neohaler Dual Bronchodilator for COPD
COPD, News
Novartis announced that the FDA recently approved the dual combined bronchodilator Utibron™ Neohaler® (indacaterol/glycopyrrolate), an inhalation powder for long-term maintenance therapy of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including ... Read more